PFAS Research and Development Reauthorization Act of 2025

#6667 | HR Congress #119

Subjects:

Last Action: Referred to the Subcommittee on Water Resources and Environment. (2/2/2026)

Bill Text Source: Congress.gov

Summary and Impacts
Original Text

Bill Summary

The "PFAS Research and Development Reauthorization Act of 2025" is legislation aimed at extending funding for research and development related to per- and polyfluoroalkyl substances (PFAS) by the Environmental Protection Agency (EPA). The bill amends an existing law, specifically the National Defense Authorization Act for Fiscal Year 2020, by changing the expiration date for funding authorization from 2024 to 2030. This extension is intended to support ongoing efforts to understand and address the environmental and health impacts of PFAS.

Possible Impacts

Here are three examples of how the "PFAS Research and Development Reauthorization Act of 2025" could affect people:

1. **Health and Safety Improvements**: The extension of funding for PFAS (per- and polyfluoroalkyl substances) research could lead to better understanding and management of health risks associated with exposure to these chemicals. As a result, communities that have been impacted by PFAS contamination might see improved health outcomes and reduced incidences of related diseases, such as cancer or liver damage.

2. **Environmental Remediation**: Increased funding for PFAS research may facilitate the development of better technologies and methods for cleaning up contaminated sites, such as military bases or industrial areas. This could lead to improved environmental conditions for residents living near these sites, ultimately enhancing their quality of life and property values.

3. **Regulatory Changes and Consumer Protection**: With more research, the EPA could establish stricter regulations on PFAS usage and emissions. This might lead to the phasing out of certain PFAS products and greater consumer protection from hazardous chemicals in everyday items, like food packaging or household goods. Consumers could benefit from safer products, reducing their exposure to potentially harmful substances.

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6667 Introduced in House (IH)]

<DOC>






119th CONGRESS
  1st Session
                                H. R. 6667

  To extend the authorization of appropriations for PFAS research and 
          development by the Environmental Protection Agency.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           December 11, 2025

 Mr. Pappas (for himself and Mr. Fitzpatrick) introduced the following 
 bill; which was referred to the Committee on Energy and Commerce, and 
 in addition to the Committees on Science, Space, and Technology, and 
  Transportation and Infrastructure, for a period to be subsequently 
   determined by the Speaker, in each case for consideration of such 
 provisions as fall within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
  To extend the authorization of appropriations for PFAS research and 
          development by the Environmental Protection Agency.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``PFAS Research and Development 
Reauthorization Act of 2025''.

SEC. 2. AUTHORIZATION.

    Section 7362(b) of the National Defense Authorization Act for 
Fiscal Year 2020 (15 U.S.C. 8962(b)) is amended by striking ``2024'' 
and inserting ``2030''.
                                 <all>